This company has been acquired
La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
DICE Therapeutics Gestione
Gestione criteri di controllo 2/4
We currently do not have sufficient information about the CEO.
Informazioni chiave
J. Judice
Amministratore delegato
US$5.8m
Compenso totale
Percentuale dello stipendio del CEO | 9.4% |
Mandato del CEO | 10yrs |
Proprietà del CEO | 1.7% |
Durata media del management | 2.6yrs |
Durata media del Consiglio di amministrazione | 2.7yrs |
Aggiornamenti recenti sulla gestione
Recent updates
We're Not Very Worried About DICE Therapeutics' (NASDAQ:DICE) Cash Burn Rate
May 14DICE Therapeutics positive phase 1 data for psoriasis candidate leads shares 71% higher
Oct 11Here's Why We're Not Too Worried About DICE Therapeutics' (NASDAQ:DICE) Cash Burn Situation
Sep 11DICE Therapeutics GAAP EPS of -$0.58
Aug 11DICE Therapeutics initiated at buy at Wainwright on platform for small molecule drugs
Jul 18Analisi delle retribuzioni degli amministratori delegati
Data | Compenso totale | Stipendio | Guadagni aziendali |
---|---|---|---|
Jun 30 2023 | n/a | n/a | -US$104m |
Mar 31 2023 | n/a | n/a | -US$91m |
Dec 31 2022 | US$6m | US$540k | -US$84m |
Sep 30 2022 | n/a | n/a | -US$77m |
Jun 30 2022 | n/a | n/a | -US$74m |
Mar 31 2022 | n/a | n/a | -US$59m |
Dec 31 2021 | US$6m | US$465k | -US$49m |
Sep 30 2021 | n/a | n/a | -US$40m |
Jun 30 2021 | n/a | n/a | -US$29m |
Mar 31 2021 | n/a | n/a | -US$27m |
Dec 31 2020 | US$637k | US$437k | -US$24m |
Compensazione vs Mercato: J.'s total compensation ($USD5.77M) is about average for companies of similar size in the US market ($USD5.11M).
Compensazione vs guadagni: J.'s compensation has increased whilst the company is unprofitable.
AMMINISTRATORE DELEGATO
J. Judice (59 yo)
10yrs
Mandato
US$5,773,577
Compensazione
Dr. J. Kevin Judice, Ph D., founded DiCE Molecules SV, Inc. (formerly known as DiCE Molecules Corp). and serves as its Chief Executive Officer, President and Secretary. Dr. Judice has extensive experience...
Gruppo dirigente
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
Founder | 10yrs | US$5.77m | 1.67% $ 38.0m | |
Chief Business & Financial Officer | 5.7yrs | US$2.67m | 0.41% $ 9.4m | |
Chief Medical Officer | 3yrs | US$2.72m | 0.32% $ 7.2m | |
Chief Scientific Officer | 2.2yrs | US$714.79k | 0.31% $ 7.0m | |
General Counsel | 1.4yrs | Nessun dato | Nessun dato | |
Senior Vice President of CMC | 2.2yrs | Nessun dato | Nessun dato | |
Senior Vice President of Medicinal Chemistry | no data | Nessun dato | Nessun dato |
2.6yrs
Durata media
54yo
Età media
Gestione esperta: DICE's management team is considered experienced (2.6 years average tenure).
Membri del Consiglio di amministrazione
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
Founder | no data | US$5.77m | 1.67% $ 38.0m | |
Independent Director | 2.8yrs | US$264.90k | 0.10% $ 2.4m | |
Independent Chairman of the Board | 7.7yrs | US$371.88k | 0.018% $ 400.6k | |
Independent Director | 2.8yrs | US$264.90k | 0.086% $ 1.9m | |
Independent Director | 1.4yrs | US$552.51k | 0% $ 0 | |
Independent Director | 2.7yrs | US$231.45k | Nessun dato | |
Independent Director | 1.4yrs | US$552.51k | 0% $ 0 |
2.7yrs
Durata media
59yo
Età media
Consiglio di amministrazione esperto: DICE's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.